ROYALTY PURCHASE AGREEMENT Dated as of August 12, 2010 by and among XOMA CDRA LLC, XOMA (US) LLC, XOMA LTD., AND ORBIMED ADVISORS, LLCRoyalty Purchase Agreement • April 13th, 2011 • Xoma LTD /De/ • Pharmaceutical preparations • New York
This ROYALTY PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of August 12, 2010 (the “Effective Date”) by and among XOMA CDRA LLC, a Delaware limited liability company (“Seller”), XOMA Ltd., a Bermuda company, solely for the purposes of Article V, Article VII, Article VIII, Section 6.01(a), Section 6.02, Section 6.03, Section 6.04(a), Section 6.04(d), Section 6.04(g) and Section 6.06 and Section 6.07 (“XOMA”), XOMA (US) LLC, a Delaware limited liability company and the direct, 100% owner of Seller, solely for the purposes of Section 3.11(d), Section 3.11(i), Section 3.11(k), Section 6.01(a), Section 6.02, Section 6.03, Section 6.04(a), Section 6.04(d), Section 6.04(g), Section 6.06, Section 6.07, Article V, Article VII, and Article VIII (“Seller Parent”) and OrbiMed Advisors, LLC, a Delaware limited liability company (“Purchaser”).
